BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaminski RM, Rogawski MA, Klitgaard H. The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments. Neurotherapeutics 2014;11:385-400. [PMID: 24671870 DOI: 10.1007/s13311-014-0266-1] [Cited by in Crossref: 66] [Cited by in F6Publishing: 55] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Kyllo T, Singh V, Shim H, Latika S, Nguyen HM, Chen Y, Terry E, Wulff H, Erickson JD. Riluzole and novel naphthalenyl substituted aminothiazole derivatives prevent acute neural excitotoxic injury in a rat model of temporal lobe epilepsy. Neuropharmacology 2022. [DOI: 10.1016/j.neuropharm.2022.109349] [Reference Citation Analysis]
2 Kılıç Ü, Demir Ş, Beyazçiçek E, Beyazçiçek Ö, Soytürk H. The Effects of Acute and Chronic Metformin Treatment on Penicillin Induced Epileptiform Activity in Rats. jarem 2022;12:87-98. [DOI: 10.4274/jarem.galenos.2022.25238] [Reference Citation Analysis]
3 Chen M, Edwards SR, Reutens DC. Complement in the Development of Post-Traumatic Epilepsy: Prospects for Drug Repurposing. J Neurotrauma 2020;37:692-705. [PMID: 32000582 DOI: 10.1089/neu.2019.6942] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
4 Yu N, Lin XJ, Di Q. How to Find Candidate Drug-targets for Antiepileptogenic Therapy? Curr Neuropharmacol 2020;18:624-35. [PMID: 31989901 DOI: 10.2174/1570159X18666200128124338] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Mihály I, Molnár T, Berki ÁJ, Bod RB, Orbán-Kis K, Gáll Z, Szilágyi T. Short-Term Amygdala Low-Frequency Stimulation Does not Influence Hippocampal Interneuron Changes Observed in the Pilocarpine Model of Epilepsy. Cells 2021;10:520. [PMID: 33804543 DOI: 10.3390/cells10030520] [Reference Citation Analysis]
6 Kamiński K, Socała K, Zagaja M, Andres-Mach M, Abram M, Jakubiec M, Pieróg M, Nieoczym D, Rapacz A, Gawel K, Esguerra CV, Latacz G, Lubelska A, Szulczyk B, Szewczyk A, Łuszczki JJ, Wlaź P. N-Benzyl-(2,5-dioxopyrrolidin-1-yl)propanamide (AS-1) with Hybrid Structure as a Candidate for a Broad-Spectrum Antiepileptic Drug. Neurotherapeutics 2020;17:309-28. [PMID: 31486023 DOI: 10.1007/s13311-019-00773-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
7 Welzel L, Bergin DH, Schidlitzki A, Twele F, Johne M, Klein P, Löscher W. Systematic evaluation of rationally chosen multitargeted drug combinations: a combination of low doses of levetiracetam, atorvastatin and ceftriaxone exerts antiepileptogenic effects in a mouse model of acquired epilepsy. Neurobiol Dis 2021;149:105227. [PMID: 33347976 DOI: 10.1016/j.nbd.2020.105227] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
8 Czyżewska I, Kuśmierz E, Wujec M. 4-Alkyl-1-(2-fluorobenzoyl)thiosemicarbazides and products of their de-hydrocyclization as compounds with potential anticonvulsant activity. Biopolym Cell 2020;36:371-380. [DOI: 10.7124/bc.000a3b] [Reference Citation Analysis]
9 Klein P, Friedman A, Hameed MQ, Kaminski RM, Bar-Klein G, Klitgaard H, Koepp M, Jozwiak S, Prince DA, Rotenberg A, Twyman R, Vezzani A, Wong M, Löscher W. Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy? Epilepsia 2020;61:359-86. [PMID: 32196665 DOI: 10.1111/epi.16450] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 17.5] [Reference Citation Analysis]
10 Obniska J, Góra M, Rapacz A, Sałat K, Rybka S, Abram M, Jakubiec M, Kamiński K. Synthesis, anticonvulsant, and antinociceptive activity of new 3-(3-methyl-2,5-dioxo-3-phenylpyrrolidin-1-yl)propanamides and 3-phenyl-butanamides. Arch Pharm (Weinheim) 2021;354:e2000225. [PMID: 32939789 DOI: 10.1002/ardp.202000225] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Hernandez-Ronquillo L, Miranzadeh Mahabadi H, Moien-Afshari F, Wu A, Auer R, Zherebitskiy V, Borowsky R, Mickleborough M, Huntsman R, Vrbancic M, Cayabyab FS, Taghibiglou C, Carter A, Tellez-Zenteno JF. The Concept of an Epilepsy Brain Bank. Front Neurol 2020;11:833. [PMID: 32973652 DOI: 10.3389/fneur.2020.00833] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Shen HY, Weltha L, Cook JM, Gesese R, Omi W, Baer SB, Rose RM, Reemmer J, Boison D. Sarcosine Suppresses Epileptogenesis in Rats With Effects on Hippocampal DNA Methylation. Front Mol Neurosci 2020;13:97. [PMID: 32581708 DOI: 10.3389/fnmol.2020.00097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Ramos AB, Cruz RA, Villemarette-Pittman NR, Olejniczak PW, Mader EC Jr. Dexamethasone as Abortive Treatment for Refractory Seizures or Status Epilepticus in the Inpatient Setting. J Investig Med High Impact Case Rep 2019;7:2324709619848816. [PMID: 31104535 DOI: 10.1177/2324709619848816] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
14 Song JH, Bae SM, Bae WR, Huh JS, Chen Y, Jeong IS, Jung DI. Synthesis and Antiepileptic Activity Evaluation of Valproic Acid Derivatives by Niche Chemistry. Bull Korean Chem Soc 2020;41:558-62. [DOI: 10.1002/bkcs.12010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Yue J, Wei YJ, Yang XL, Liu SY, Yang H, Zhang C‐. NLRP3 inflammasome and endoplasmic reticulum stress in the epileptogenic zone in temporal lobe epilepsy: molecular insights into their interdependence. Neuropathol Appl Neurobiol 2020;46:770-85. [DOI: 10.1111/nan.12621] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 7.5] [Reference Citation Analysis]
16 Dhir A. Natural polyphenols in preclinical models of epilepsy. Phytotherapy Research 2020;34:1268-81. [DOI: 10.1002/ptr.6617] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
17 Eastman CL, D'Ambrosio R, Ganesh T. Modulating neuroinflammation and oxidative stress to prevent epilepsy and improve outcomes after traumatic brain injury. Neuropharmacology 2020;172:107907. [PMID: 31837825 DOI: 10.1016/j.neuropharm.2019.107907] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 11.7] [Reference Citation Analysis]
18 Schidlitzki A, Bascuñana P, Srivastava PK, Welzel L, Twele F, Töllner K, Käufer C, Gericke B, Feleke R, Meier M, Polyak A, Ross TL, Gerhauser I, Bankstahl JP, Johnson MR, Bankstahl M, Löscher W. Proof-of-concept that network pharmacology is effective to modify development of acquired temporal lobe epilepsy. Neurobiol Dis 2020;134:104664. [PMID: 31678583 DOI: 10.1016/j.nbd.2019.104664] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
19 Gericke B, Brandt C, Theilmann W, Welzel L, Schidlitzki A, Twele F, Kaczmarek E, Anjum M, Hillmann P, Löscher W. Selective inhibition of mTORC1/2 or PI3K/mTORC1/2 signaling does not prevent or modify epilepsy in the intrahippocampal kainate mouse model. Neuropharmacology 2020;162:107817. [PMID: 31654704 DOI: 10.1016/j.neuropharm.2019.107817] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
20 Klein P, Tyrlikova I. No prevention or cure of epilepsy as yet. Neuropharmacology 2020;168:107762. [PMID: 31499048 DOI: 10.1016/j.neuropharm.2019.107762] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
21 Bai Y, He X, Bai Y, Sun Y, Zhao Z, Chen X, Li B, Xie J, Li Y, Jia P, Meng X, Zhao Y, Ding Y, Xiao C, Wang S, Yu J, Liao S, Zhang Y, Zhu Z, Zhang Q, Zhao Y, Qin F, Zhang Y, Wei X, Zeng M, Liang J, Cuan Y, Shan G, Fan TP, Wu B, Zheng X. Polygala tenuifolia-Acori tatarinowii herbal pair as an inspiration for substituted cinnamic α-asaronol esters: Design, synthesis, anticonvulsant activity, and inhibition of lactate dehydrogenase study. Eur J Med Chem 2019;183:111650. [PMID: 31539780 DOI: 10.1016/j.ejmech.2019.111650] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
22 Yu Y, Nguyen DT, Jiang J. G protein-coupled receptors in acquired epilepsy: Druggability and translatability. Prog Neurobiol 2019;183:101682. [PMID: 31454545 DOI: 10.1016/j.pneurobio.2019.101682] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
23 Miziak B, Walczak A, Szponar J, Pluta R, Czuczwar SJ. Drug-drug interactions between antiepileptics and cannabinoids. Expert Opinion on Drug Metabolism & Toxicology 2019;15:407-15. [DOI: 10.1080/17425255.2019.1605355] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
24 Löscher W. The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments. Neuropharmacology 2020;167:107605. [PMID: 30980836 DOI: 10.1016/j.neuropharm.2019.04.011] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 17.7] [Reference Citation Analysis]
25 Walters DC, Arning E, Bottiglieri T, Jansen EEW, Salomons GS, Brown MN, Schmidt MA, Ainslie GR, Roullet JB, Gibson KM. Metabolomic analyses of vigabatrin (VGB)-treated mice: GABA-transaminase inhibition significantly alters amino acid profiles in murine neural and non-neural tissues. Neurochem Int 2019;125:151-62. [PMID: 30822440 DOI: 10.1016/j.neuint.2019.02.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
26 Welzel L, Twele F, Schidlitzki A, Töllner K, Klein P, Löscher W. Network pharmacology for antiepileptogenesis: Tolerability and neuroprotective effects of novel multitargeted combination treatments in nonepileptic vs. post-status epilepticus mice. Epilepsy Res 2019;151:48-66. [PMID: 30831337 DOI: 10.1016/j.eplepsyres.2019.02.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
27 Yimer EM, Surur A, Wondafrash DZ, Gebre AK. The Effect of Metformin in Experimentally Induced Animal Models of Epileptic Seizure. Behav Neurol 2019;2019:6234758. [PMID: 30863464 DOI: 10.1155/2019/6234758] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
28 Fageyinbo MS, Odumeso AO, Rotimi K, Fasipe OJ, Olayemi SO. Anticonvulsant, anxiolytic and sedative activities of hydro-ethanolic leaf extract of Mitragyna stipulosa. Journal of Herbs, Spices & Medicinal Plants 2019;25:43-54. [DOI: 10.1080/10496475.2018.1556373] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Bordet R, Carton L, Deguil J, Dondaine T. Pharmacologie des antiépileptiques. Neuropsychopharmacologie 2019. [DOI: 10.1016/b978-2-294-75299-5.00020-4] [Reference Citation Analysis]
30 Dhir A. An update of cyclooxygenase (COX)-inhibitors in epilepsy disorders. Expert Opin Investig Drugs 2019;28:191-205. [PMID: 30521407 DOI: 10.1080/13543784.2019.1557147] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
31 Leo A, Citraro R, Amodio N, De Sarro C, Gallo Cantafio ME, Constanti A, De Sarro G, Russo E. Fingolimod Exerts only Temporary Antiepileptogenic Effects but Longer-Lasting Positive Effects on Behavior in the WAG/Rij Rat Absence Epilepsy Model. Neurotherapeutics 2017;14:1134-47. [PMID: 28653281 DOI: 10.1007/s13311-017-0550-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
32 Pitsch J, Kuehn JC, Gnatkovsky V, Müller JA, van Loo KMJ, de Curtis M, Vatter H, Schoch S, Elger CE, Becker AJ. Anti-epileptogenic and Anti-convulsive Effects of Fingolimod in Experimental Temporal Lobe Epilepsy. Mol Neurobiol 2019;56:1825-40. [PMID: 29934763 DOI: 10.1007/s12035-018-1181-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
33 Ordookhanian C, Nagappan M, Elias D, Kaloostian PE. Management of Intracranial Pressure in Traumatic Brain Injury. Traumatic Brain Injury - Pathobiology, Advanced Diagnostics and Acute Management 2018. [DOI: 10.5772/intechopen.72829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Li Q, Han Y, Du J, Jin H, Zhang J, Niu M, Qin J. Recombinant human erythropoietin protects against brain injury through blunting the mTORC1 pathway in the developing brains of rats with seizures. Life Sciences 2018;194:15-25. [DOI: 10.1016/j.lfs.2017.12.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
35 Löscher W, Gillard M, Sands ZA, Kaminski RM, Klitgaard H. Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond. CNS Drugs 2016;30:1055-77. [PMID: 27752944 DOI: 10.1007/s40263-016-0384-x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 93] [Article Influence: 22.3] [Reference Citation Analysis]
36 Fonseca BM, Rodrigues M, Alves G. First HPLC method for the simultaneous quantification of levetiracetam, zonisamide, lamotrigine, pentylenetetrazole and pilocarpine in rat plasma and brain. Anal Methods 2018;10:515-25. [DOI: 10.1039/c7ay02602a] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
37 Klein P, Dingledine R, Aronica E, Bernard C, Blümcke I, Boison D, Brodie MJ, Brooks-Kayal AR, Engel J Jr, Forcelli PA, Hirsch LJ, Kaminski RM, Klitgaard H, Kobow K, Lowenstein DH, Pearl PL, Pitkänen A, Puhakka N, Rogawski MA, Schmidt D, Sillanpää M, Sloviter RS, Steinhäuser C, Vezzani A, Walker MC, Löscher W. Commonalities in epileptogenic processes from different acute brain insults: Do they translate? Epilepsia 2018;59:37-66. [PMID: 29247482 DOI: 10.1111/epi.13965] [Cited by in Crossref: 137] [Cited by in F6Publishing: 149] [Article Influence: 27.4] [Reference Citation Analysis]
38 Rybka S, Obniska J, Żmudzki P, Koczurkiewicz P, Wójcik-Pszczoła K, Pękala E, Bryła A, Rapacz A. Synthesis and Determination of Lipophilicity, Anticonvulsant Activity, and Preliminary Safety of 3-Substituted and 3-Unsubstituted N-[(4-Arylpiperazin-1-yl)alkyl]pyrrolidine-2,5-dione Derivatives. ChemMedChem 2017;12:1848-56. [PMID: 29045762 DOI: 10.1002/cmdc.201700539] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
39 Garlet QI, Pires LDC, Milanesi LH, Marafiga JR, Baldisserotto B, Mello CF, Heinzmann BM. (+)-Dehydrofukinone modulates membrane potential and delays seizure onset by GABAa receptor-mediated mechanism in mice. Toxicol Appl Pharmacol 2017;332:52-63. [PMID: 28733205 DOI: 10.1016/j.taap.2017.07.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
40 Deng XH, Zhang X, Wang J, Ma PS, Ma L, Niu Y, Sun T, Zhou R, Yu JQ. Anticonvulsant Effect of Swertiamarin Against Pilocarpine-Induced Seizures in Adult Male Mice. Neurochem Res 2017;42:3103-13. [PMID: 28681096 DOI: 10.1007/s11064-017-2347-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
41 Klein P, Tyrlikova I. Prevention of epilepsy: Should we be avoiding clinical trials? Epilepsy Behav 2017;72:188-94. [PMID: 28647441 DOI: 10.1016/j.yebeh.2017.05.024] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
42 Obniska J, Rapacz A, Rybka S, Góra M, Żmudzki P, Kamiński K. Synthesis and Anticonvulsant Properties of New 3,3-Diphenyl-2,5-dioxo-pyrrolidin-1-yl-acetamides and 3,3-Diphenyl-propionamides: Anticonvulsant Activity of Imide/Amide Derivatives. Arch Pharm Chem Life Sci 2017;350:1600368. [DOI: 10.1002/ardp.201600368] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
43 Rybka S, Obniska J, Rapacz A, Filipek B, Żmudzki P. Synthesis and evaluation of anticonvulsant properties of new N -Mannich bases derived from pyrrolidine-2,5-dione and its 3-methyl-, 3-isopropyl, and 3-benzhydryl analogs. Bioorganic & Medicinal Chemistry Letters 2017;27:1412-5. [DOI: 10.1016/j.bmcl.2017.02.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
44 Mooney CM, Jimenez-Mateos EM, Engel T, Mooney C, Diviney M, Venø MT, Kjems J, Farrell MA, O'Brien DF, Delanty N, Henshall DC. RNA sequencing of synaptic and cytoplasmic Upf1-bound transcripts supports contribution of nonsense-mediated decay to epileptogenesis. Sci Rep 2017;7:41517. [PMID: 28128343 DOI: 10.1038/srep41517] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
45 Coles LD, Klitgaard H, Kuker M, Cloyd JC. Regulatory Aspects for Drug Development. Models of Seizures and Epilepsy 2017. [DOI: 10.1016/b978-0-12-804066-9.00006-7] [Reference Citation Analysis]
46 Feng L, Shu Y, Wu Q, Liu T, Long H, Yang H, Li Y, Xiao B. EphA4 may contribute to microvessel remodeling in the hippocampal CA1 and CA3 areas in a mouse model of temporal lobe epilepsy. Mol Med Rep 2017;15:37-46. [PMID: 27959424 DOI: 10.3892/mmr.2016.6017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
47 Terrone G, Pauletti A, Pascente R, Vezzani A. Preventing epileptogenesis: A realistic goal? Pharmacological Research 2016;110:96-100. [DOI: 10.1016/j.phrs.2016.05.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
48 Coppens J, Aourz N, Walrave L, Fehrentz J, Martinez J, De Bundel D, Portelli J, Smolders I. Anticonvulsant effect of a ghrelin receptor agonist in 6Hz corneally kindled mice. Epilepsia 2016;57:e195-9. [DOI: 10.1111/epi.13463] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
49 Fischer W, Franke H, Krügel U, Müller H, Dinkel K, Lord B, Letavic MA, Henshall DC, Engel T. Critical Evaluation of P2X7 Receptor Antagonists in Selected Seizure Models. PLoS One 2016;11:e0156468. [PMID: 27281030 DOI: 10.1371/journal.pone.0156468] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
50 Rogawski MA, Löscher W, Rho JM. Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet. Cold Spring Harb Perspect Med 2016;6:a022780. [PMID: 26801895 DOI: 10.1101/cshperspect.a022780] [Cited by in Crossref: 143] [Cited by in F6Publishing: 173] [Article Influence: 23.8] [Reference Citation Analysis]
51 Łukawski K, Gryta P, Łuszczki J, Czuczwar SJ. Exploring the latest avenues for antiepileptic drug discovery and development. Expert Opinion on Drug Discovery 2016;11:369-82. [DOI: 10.1517/17460441.2016.1154840] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
52 Klitgaard H, Matagne A, Nicolas JM, Gillard M, Lamberty Y, De Ryck M, Kaminski RM, Leclercq K, Niespodziany I, Wolff C, Wood M, Hannestad J, Kervyn S, Kenda B. Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment. Epilepsia 2016;57:538-48. [PMID: 26920914 DOI: 10.1111/epi.13340] [Cited by in Crossref: 95] [Cited by in F6Publishing: 102] [Article Influence: 15.8] [Reference Citation Analysis]
53 Fu T, Kong Q, Sheng H, Gao L. Value of Functionalized Superparamagnetic Iron Oxide Nanoparticles in the Diagnosis and Treatment of Acute Temporal Lobe Epilepsy on MRI. Neural Plast 2016;2016:2412958. [PMID: 26925269 DOI: 10.1155/2016/2412958] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
54 Krishnan SM, Sobey CG, Latz E, Mansell A, Drummond GR. IL-1β and IL-18: inflammatory markers or mediators of hypertension? Br J Pharmacol 2014;171:5589-602. [PMID: 25117218 DOI: 10.1111/bph.12876] [Cited by in Crossref: 123] [Cited by in F6Publishing: 130] [Article Influence: 17.6] [Reference Citation Analysis]
55 Bhandary S, Aguan K. Pyruvate dehydrogenase complex deficiency and its relationship with epilepsy frequency--An overview. Epilepsy Res 2015;116:40-52. [PMID: 26354166 DOI: 10.1016/j.eplepsyres.2015.07.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
56 Barker-haliski ML, Friedman D, French JA, White HS. Disease Modification in Epilepsy: From Animal Models to Clinical Applications. Drugs 2015;75:749-67. [DOI: 10.1007/s40265-015-0395-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
57 Carmen F. Molecular Targets on Antiepileptogenic Therapy Research: Deconstructing the Network for Translational Purposes. PPIJ 2015;2. [DOI: 10.15406/ppij.2015.02.00018] [Reference Citation Analysis]
58 Scharfman HE. Neuroscience. Metabolic control of epilepsy. Science 2015;347:1312-3. [PMID: 25792315 DOI: 10.1126/science.aaa9607] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
59 Coelho VR, Vieira CG, de Souza LP, Moysés F, Basso C, Papke DKM, Pires TR, Siqueira IR, Picada JN, Pereira P. Antiepileptogenic, antioxidant and genotoxic evaluation of rosmarinic acid and its metabolite caffeic acid in mice. Life Sciences 2015;122:65-71. [DOI: 10.1016/j.lfs.2014.11.009] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 7.1] [Reference Citation Analysis]
60 Rocha L, Santana-gómez C, Rosillo-de la Torre A, Magdaleno-madrigal V, Alonso-vanegas M, Velasco F, Bruno-blanch L. Epilepsy Therapeutics. Brain Mapping 2015. [DOI: 10.1016/b978-0-12-397025-1.00105-6] [Reference Citation Analysis]
61 Jehi LE, Vezzani A. Novel concepts in epileptogenesis and its prevention. Neurotherapeutics 2014;11:229-30. [PMID: 24652605 DOI: 10.1007/s13311-014-0268-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
62 Shu Y, Xiao B, Wu Q, Liu T, Du Y, Tang H, Chen S, Feng L, Long L, Li Y. The Ephrin-A5/EphA4 Interaction Modulates Neurogenesis and Angiogenesis by the p-Akt and p-ERK Pathways in a Mouse Model of TLE. Mol Neurobiol 2016;53:561-76. [PMID: 25502292 DOI: 10.1007/s12035-014-9020-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
63 Plech T, Kaproń B, Luszczki JJ, Wujec M, Paneth A, Siwek A, Kołaczkowski M, Zołnierek M, Nowak G. Studies on the anticonvulsant activity and influence on GABA-ergic neurotransmission of 1,2,4-triazole-3-thione- based compounds. Molecules 2014;19:11279-99. [PMID: 25090118 DOI: 10.3390/molecules190811279] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
64 He K, Xiao W, Lv W. Comprehensive identification of essential pathways and transcription factors related to epilepsy by gene set enrichment analysis on microarray datasets. Int J Mol Med 2014;34:715-24. [PMID: 25016997 DOI: 10.3892/ijmm.2014.1843] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]